Scientists at UC San Diego have identified a new drug, ION224, that could transform the treatment of MASH, a dangerous form of fatty liver disease tied to obesity and diabetes. By blocking a key liver ...
Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder with a complex pathogenesis. Although epitranscriptomic modifications such as N6-methyladenosine (m6A) have been implicated ...
Terms such as “complexity,” “complex systems,” and “complex adaptive systems” have moved rapidly from specialist research into the vocabularies of policy, sustainability practice, business, and health ...